Skip to main content
. Author manuscript; available in PMC: 2021 Jun 14.
Published in final edited form as: Semin Nucl Med. 2020 Jun 28;50(6):518–531. doi: 10.1053/j.semnuclmed.2020.06.001

Figure 5.

Figure 5

Example of an 89Zr-IAB22M2C a radiolabeled minibody against CD81 T cells, for imaging tumor associated CD81 T cells in patients with cancer. (A) A 24-hour whole-body (maximum-intensity projection) image with intense uptake noted in lymph nodes. (B and C) Fusion PET and CT image at 24 hours shows 89Zr-IAB22M2C uptake in a confirmed metastatic lesion in right deltoid muscle (B), which was also FDG PET positive (C) (This research was originally published in JNM. Pandit-Taskar N, et al. J Nucl Med. 2020;61(4):512–9.).97